Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Cancer immunotherapy targeting survivin: commentary re: V. Pisarev et al., full-length dominant-negative survivin for cancer immunotherapy. Clin. Cancer Res., 9:6523-6533, 2003.

× No keyword cloud information.

9 in total

1. Survivin expression by metastatic melanoma predicts poor disease outcome in patients receiving adjuvant polyvalent vaccine.

Authors: Hiroya Takeuchi; Donald L Morton; David Elashoff; Dave S B Hoon
Journal: Int J Cancer Date: 2005-12-20 Impact factor: 7.396

2. Knockdown of survivin expression by siRNA induces apoptosis of hepatocellular carcinoma cells.

Authors: Liang Wu; Ying Wang; Deying Tian
Journal: J Huazhong Univ Sci Technolog Med Sci Date: 2007-08

3. Dissociation of its opposing immunologic effects is critical for the optimization of antitumor CD8+ T-cell responses induced by interleukin 21.

Authors: Sascha Ansén; Marcus O Butler; Alla Berezovskaya; Andrew P Murray; Kristen Stevenson; Lee M Nadler; Naoto Hirano
Journal: Clin Cancer Res Date: 2008-10-01 Impact factor: 12.531

Review 4. Survivin: potential role in diagnosis, prognosis and targeted therapy of gastric cancer.

Authors: Ting-Ting Wang; Xiao-Ping Qian; Bao-Rui Liu
Journal: World J Gastroenterol Date: 2007-05-28 Impact factor: 5.742

5. Survivin expression in ovarian cancer and its correlation with clinico-pathological, surgical and apoptosis-related parameters.

Authors: G Ferrandina; F Legge; E Martinelli; F O Ranelletti; G F Zannoni; L Lauriola; M Gessi; V Gallotta; G Scambia
Journal: Br J Cancer Date: 2005-01-31 Impact factor: 7.640

Review 6. Survivin, a molecular target for therapeutic interventions in squamous cell carcinoma.

Authors: Zakir Khan; Abdul Arif Khan; Hariom Yadav; Godavarthi B K S Prasad; Prakash Singh Bisen
Journal: Cell Mol Biol Lett Date: 2017-04-05 Impact factor: 5.787

7. Design of Peptide-Based Nanovaccines Targeting Leading Antigens From Gynecological Cancers to Induce HLA-A2.1 Restricted CD8⁺ T Cell Responses.

Authors: Sue D Xiang; Kirsty L Wilson; Anne Goubier; Arne Heyerick; Magdalena Plebanski
Journal: Front Immunol Date: 2018-12-21 Impact factor: 7.561

Review 8. Wnt-Independent and Wnt-Dependent Effects of APC Loss on the Chemotherapeutic Response.

Authors: Casey D Stefanski; Jenifer R Prosperi
Journal: Int J Mol Sci Date: 2020-10-22 Impact factor: 5.923

Review 9. Emerging Importance of Survivin in Stem Cells and Cancer: the Development of New Cancer Therapeutics.

Authors: Neerada Meenakshi Warrier; Prasoon Agarwal; Praveen Kumar
Journal: Stem Cell Rev Rep Date: 2020-10 Impact factor: 5.739